DERMALIQ THERAPEUTICS
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQâ„¢, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the development of effective liquid drug products with exceptional cosmetic properties.
DERMALIQ THERAPEUTICS
Industry:
Fitness Health Care Pharmaceutical Wellness
Founded:
2022-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.dermaliq.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M USD
Similar Organizations
100Plus
100Plus is the fastest-growing Remote Patient Monitoring Platform for doctors to manage their chronic patients to avoid episodic care.
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
NeuroFlow
NeuroFlow is a digital health company.
Circuit Living
Circuit Living is the nation's premier tech-enabled amenities provider designed specifically for residential and commercial communities.
Current Advisors List
Current Employees Featured
Investors List
Beijing Whale Technology Corporation
Beijing Whale Technology Corporation investment in Series A - Dermaliq Therapeutics
3E Bioventures
3E Bioventures investment in Series A - Dermaliq Therapeutics
Official Site Inspections
http://www.dermaliq.com
- Host name: 217-160-0-203.elastic-ssl.ui-r.com
- IP address: 217.160.0.203
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
